{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:09:34Z","timestamp":1788786574459,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In line with current guidelines, risk stratification in papillary thyroid microcarcinoma (PTMC) has shifted from simple diameter-based assessments to evaluation of individual tumor biology. Therefore, this study aimed to investigate how baseline clinical and molecular risk factors influence aggressive PTMC phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Registered in PROSPERO (CRD42024603662), we searched PubMed, Embase, and Cochrane through February 14, 2025. We analyzed risk factors for lymph node metastasis (LNM) and extrathyroidal extension (ETE) utilizing data from surgical cohorts of patients with PTMC, calculating pooled odds ratios (OR) and 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 274 articles we found increased odds of central lymph node metastasis (CLNM) associated with male sex (OR\u00a0=\u00a01.86; CI:1.73\u20132.00), age (&amp;lt;45 and &amp;lt;55 years old OR\u00a0=\u00a01.61; CI:1.42\u20131.83 and OR\u00a0=\u00a01.89; CI:1.71\u20132.09), tumor size (&amp;gt;5 and &amp;gt;7\u00a0mm OR\u00a0=\u00a02.26; CI:2.00\u20132.56 and OR\u00a0=\u00a01.81; CI:1.11\u20132.96), multifocality (OR\u00a0=\u00a01.96; CI:1.78\u20132.16), bilaterality (OR\u00a0=\u00a01.70; CI:1.45\u20132.00) and BRAFV600E mutation (OR\u00a0=\u00a01.51; CI:1.25\u20131.82). Lateral lymph node metastasis (LLNM) was associated with male sex (OR\u00a0=\u00a01.69; CI:1.51\u20131.90), age (&amp;lt;45 and &amp;lt;55 years old OR\u00a0=\u00a01.5; CI:1.28\u20131.76 and CI:1.31\u20131.72), tumor size (&amp;gt;5\u00a0mm and &amp;gt;7\u00a0mm, OR\u00a0=\u00a02.34; CI:1.68\u20133.25 and OR\u00a0=\u00a03.71; CI:3.15\u20134.36), multifocality (OR\u00a0=\u00a01.98; CI:1.46\u20132.70) and bilaterality (OR\u00a0=\u00a01.91; CI:1.22\u20133.00). For ETE, risk factors were as follows: tumor size (&amp;gt;5\u00a0mm OR\u00a0=\u00a03.00; CI:2.03\u20134.45), multifocality (OR\u00a0=\u00a02.41; CI:1.99\u20132.91), bilaterality (OR\u00a0=\u00a02.58; CI:1.26\u20135.27), and BRAFV600E mutation (OR\u00a0=\u00a02.19; CI:1.61\u20132.97).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Male sex, age (&amp;lt;45 and &amp;lt;55 years), tumor size (&amp;gt;5\u00a0mm), multifocality, bilaterality, and BRAF\n                      <jats:sup>V600E<\/jats:sup>\n                      mutation are clinically relevant risk factors for aggressive PTMC phenotypes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024603662<\/jats:ext-link>\n                      , identifier CRD42024603662.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1876912","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:25:15Z","timestamp":1782966315000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors associated with aggressive tumor phenotypes in papillary thyroid microcarcinoma: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"M\u00e1t\u00e9","family":"Orgov\u00e1nyi","sequence":"first","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]},{"name":"Department of Internal Medicine, Uzsoki Hospital","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anett","family":"Rancz","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]},{"name":"Department of Rheumatology and Immunology, Semmelweis University","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Dolhascu","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]},{"name":"Department of Pneumology, Institute of Pneumology \u201cMarius Nasta\u201d","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Ag\u00f3cs","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]},{"name":"Department of Biophysics and Radiation Biology, Semmelweis University","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogl\u00e1rka Lilla","family":"Szentes","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"Sipter","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]},{"name":"Department of Internal Medicine and Haematology, Semmelweis University","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]},{"name":"Institute for Translational Medicine, Medical School, University of P\u00e9cs","place":["P\u00e9cs, Hungary"]},{"name":"Institute of Pancreatic Diseases, Semmelweis University","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor L\u00e1szl\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine, Semmelweis University","place":["Budapest, Hungary"]},{"name":"Department of Internal Medicine, North-Pest Central Hospital \u2013 Military Hospital","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/jhnps.jhnps_44_23","article-title":"Thyroid papillary microcarcinoma - carcinoma with clinically benign behaviour","volume":"11","author":"Singhavi","year":"2023","journal-title":"J Head Neck Phys Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.5.676","article-title":"Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0845","article-title":"Active surveillance for papillary thyroid microcarcinoma in a population with restrictive diagnostic workup strategies","volume":"31","author":"Loncar","year":"2021","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.18528","article-title":"Changes in trends in thyroid cancer incidence in the United States, 1992 to 2016","volume":"322","author":"Powers","year":"2019","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.13201\/j.issn.2096-7993.2021.08.010","article-title":"Comparison of the diagnostic value of high frequency ultrasound and ultrasound-guided fine needle aspiration biopsy in papillary thyroid microcarcinoma","volume":"35","author":"Qin","year":"2021","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"B6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03315-w","article-title":"Systems education can train the next generation of scientists and clinicians","volume":"30","author":"Hegyi","year":"2024","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051532","article-title":"Academia Europaea position paper on translational medicine: the cycle model for translating scientific results into community benefits","volume":"9","author":"Hegyi","year":"2020","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-2-76","article-title":"Cochrane methods \u2013 twenty years experience in developing systematic review methods","volume":"2","author":"Chandler","year":"2013","journal-title":"Syst Rev"},{"key":"B11","unstructured":"Metafor: Meta-Analysis Package for R\n          \n          \n            \n              Viechtbauer\n              W\n            \n          \n          \n          2024"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res Synth Methods"},{"key":"B13","article-title":"R: A Language and Environment for Statistical Computing","year":"2024"},{"key":"B14","article-title":"Meta: General Package for Meta-Analysis (Version 7.0.0) [Computer Software]","author":"Schwarzer","year":""},{"key":"B15","unstructured":"Dmetar: Companion R Package for the Guide Doing Meta-Analysis in R (Version 0.1.0) [Computer Software]\n          \n          \n            \n              Cuijpers\n              P\n            \n            \n              Furukawa\n              T\n            \n            \n              Ebert\n              DD\n            \n          \n          \n          2024"},{"key":"B16","first-page":"41","article-title":"MetaBoostR: A validated and modular R framework for automated, reproducible meta-analysis across diverse effect measures [abstract","author":"Andrea","year":"2025"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1201\/9781003107347","volume-title":"Doing Meta-Analysis With R: A Hands-on Guide","author":"Harrer","year":"2021"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad109","article-title":"Effect of pregnancy and menopause on micropapillary thyroid carcinomas during active surveillance","volume":"7","author":"Ghirri","year":"2023","journal-title":"J Endocr Soc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1235006","article-title":"Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance","volume":"14","author":"Ding","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0539","article-title":"Active surveillance versus thyroid surgery for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0624","article-title":"Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients: active surveillance or immediate surgery (interim analysis of Maestro)","volume":"29","author":"Kong","year":"2019","journal-title":"Thyroid"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0313","article-title":"Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery","volume":"26","author":"Oda","year":"2016","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0420","article-title":"Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery","volume":"30","author":"Yoshida","year":"2020","journal-title":"Thyroid"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-25-0013","article-title":"Active surveillance for low-risk papillary thyroid microcarcinoma: a web-survey on clinician readiness for change","volume":"14","author":"Effraimidis","year":"2025","journal-title":"Eur Thyroid J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn115807-20231211-00185","article-title":"Analysis of the initial results of active surveillance of the papillary thyroid microcarcinoma and related factors for its progress","volume":"18","author":"Ge","year":"2024","journal-title":"Chin J Endocr Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0614","article-title":"Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea","volume":"32","author":"Lee","year":"2022","journal-title":"Thyroid"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-4026","article-title":"Active surveillance for patients with papillary thyroid microcarcinoma: a single center's experience in Korea","volume":"102","author":"Kwon","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-021-06185-2","article-title":"Multifocality and progression of papillary thyroid microcarcinoma during active surveillance","volume":"45","author":"Nagaoka","year":"2021","journal-title":"World J Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0393","article-title":"Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital","volume":"26","author":"Ito","year":"2016","journal-title":"Thyroid"},{"key":"B30","doi-asserted-by":"crossref","first-page":"A868","DOI":"10.1210\/jendso\/bvab048.1772","article-title":"Pregnancy during active surveillance of papillary thyroid microcarcinoma","volume":"5","author":"Rosario","year":"2021","journal-title":"J Endocr Soc"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0527","article-title":"Papillary thyroid microcarcinoma might progress during pregnancy","volume":"24","author":"Shindo","year":"2014","journal-title":"Thyroid"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.01.013","article-title":"Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? A preliminary investigation in a Chinese population","volume":"28","author":"Liu","year":"2022","journal-title":"Endocr Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"key":"B34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","article-title":"An observational trial for papillary thyroid microcarcinoma in Japanese patients","volume":"34","author":"Ito","year":"2010","journal-title":"World J Surg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12957-022-02573-7","article-title":"Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis","volume":"20","author":"Wen","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03812-5","article-title":"Risk factors for tumor enlargement in low-risk papillary thyroid microcarcinoma patients: a systematic review and meta-analysis","volume":"85","author":"Luo","year":"2024","journal-title":"Endocrine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/thy.2012.0269","article-title":"Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin","volume":"23","author":"Nilubol","year":"2013","journal-title":"Thyroid"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7580.2010.01213.x","article-title":"Age-dependent histoarchitectural changes in human lymph nodes: an underestimated process with clinical relevance","volume":"216","author":"Hadamitzky","year":"2010","journal-title":"J Anat"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-25-0119","article-title":"Pt1a papillary thyroid carcinomas in pediatric patients","volume":"14","author":"Lai","year":"2025","journal-title":"Eur Thyroid J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70225-6","article-title":"Iodine deficiency and thyroid disorders","volume":"3","author":"Zimmermann","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.1034","article-title":"Association between iodine intake, thyroid function, and papillary thyroid cancer: a case-control study","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01458-8","article-title":"Accelerating the translational medicine cycle: the Academia Europaea pilot","volume":"27","author":"Hegyi","year":"2021","journal-title":"Nat Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1876912\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:25:24Z","timestamp":1782966324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1876912\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":42,"alternative-id":["10.3389\/fendo.2026.1876912"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1876912","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1876912"}}